Return-Path: Delivered-To: andrew@sterlingcal.com Received: from reseller401.webserversystems.com by reseller401.webserversystems.com with LMTP id QDxFDJEXv2faFwAAchKAPA (envelope-from ) for ; Wed, 26 Feb 2025 07:30:57 -0600 Return-path: Envelope-to: andrew@sterlingcal.com Delivery-date: Wed, 26 Feb 2025 07:30:57 -0600 Received: from r66.info.wiley.com ([172.82.209.66]:11314) by reseller401.webserversystems.com with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384 (Exim 4.98.1) (envelope-from ) id 1tnHV2-000000003gv-32BV for andrew@sterlingcal.com; Wed, 26 Feb 2025 07:30:57 -0600 DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=info.wiley.com; s=wileypublishing; t=1740576645; bh=zic5gGqpgKZpvJHEBLmASq74nPJ9KWdLhZ0rYAUKqCI=; h=From:Subject:Date:To:MIME-Version:Message-ID:List-Unsubscribe: Content-Type; b=RFluwRBBcwg5hH+IzwEz6z3cSrpGAdrUpFZjd9m6523uHJ0usY7cZ5rq/nG9zCYPI BjSRheBt2PsejAivMN3OUBiq9pc+B6gklfbaalFeZpzyrtnKabSVhG5JT4knmrC6vD 3r/kVuB3EfvrvKryywJgKFQ+n+R5Mr1Yeh8P4H382u9izUZxsXR+Hfid054bAW+IpV J/5y4eOCMpsU3jeCc6PvTuFlLS9v9V5GTHCJIFtMcCZ3Oq8jPp6tiv2EuVEbuR1khn jGPU84d6CFn4plCrex1+AAmX6BzI8W2f9bHdbSBzOf1izY0S65Z022mtNJVZDuIPkM jDQ3qCjD/u29Q== X-MSFBL: oeVUe4MTzphCahRh/EOoL4YmX9X5wXaaQIheu6CDx7E=|eyJiIjoiYXdzX3dpbGV 5cHVibGlzaGluZ19wcm9kN19wcm9kLmpvaG53aWxleW1hcmtldGluZ19tb21lbnR 1bTU2X210YTAwM18xNzIuODIuMjA5LjY2IiwiciI6ImFuZHJld0BzdGVybGluZ2N hbC5jb20iLCJyY3B0X21ldGEiOnsgImluIjogIndpbGV5cHVibGlzaGluZ19taWR fcHJvZDciLCAiciI6ICJhbmRyZXdAc3RlcmxpbmdjYWwuY29tIiwgIm0iOiAiM2J hMDMwMmQtMTlhMy00NzVjLThkMDktNWQ4ODRjZWIwMGRhIiwgImQiOiAiNzMwNjE zNyIsICJpIjogIjFCNkUzNEI4NTI4MkEwQUMwQTQ5MEQ0NEBBZG9iZU9yZyIgfSw iZyI6InByb2Quam9obndpbGV5bWFya2V0aW5nXzlmYmFmN2YwLTU2N2QtNDVhOS1 hYjJlLTQwOGM5YzU2YTY3NSJ9 Received: from [10.182.124.226] ([10.182.124.226:56231] helo=r69.info.wiley.com) by momentum56.or1.cpt.adobe.net (envelope-from ) (ecelerity 4.2.38.999 r(:)) with ESMTP id A0/FD-11838-5871FB76; Wed, 26 Feb 2025 05:30:45 -0800 From: "Wiley" Subject: Discover the Latest CAR-T Therapy Breakthroughs Date: Wed, 26 Feb 2025 08:30:35 -0500 To: Reply-To: "Wiley" MIME-Version: 1.0 X-mailer: nlserver, Build 8.6.2 Message-ID: List-Unsubscribe: Content-Type: text/html; charset="windows-1252" Content-Transfer-Encoding: quoted-printable X-Spam-Status: No, score=-4.0 X-Spam-Score: -39 X-Spam-Bar: ---- X-Spam-Flag: NO
Find out more about personalized medicine
 
3D"Wiley"
 
 
 
Delve into th= e revolutionary advancements in CAR-T therapy and its impact on the treatme= nt of cancer, autoimmune, and rare diseases. This eBook explores two innova= tive forms of T-cell therapy that are at the forefront of this research: Ch= imeric Antigen Receptor T-cell (CAR-T) therapy and T-cell Receptor (TCR) th= erapy.

Read about how CAR-T therapy is helping evolve the treatment of cancer and = autoimmune and rare diseases and the benefit to your patients and research.
What you will learn:
•
<= span style=3D"font-size: 14px;">Advanced T-cell engineering techniques.
•
<= span style=3D"font-size: 14px;">Optimization of T-cell production processes= .
•
<= span style=3D"font-size: 14px;">Novel therapeutic strategies for personaliz= ed medicine.
These insights will provide yo= u with a deeper understanding of how these therapies work and their potenti= al to transform patient care.
 
This has be= en sponsored by Thermo Fisher Scientific.
 

3D"Facebook"  = ;     3D"X" &nb= sp;         =   3D"Instagram"

     

This message was sent to andrew@sterlingcal= .com by John Wiley & S= ons, Inc.

Americas: 111 River Street | Hoboken, NJ 07030-5774 USA | +1 877 = 762 2974
EMEA: New Era House, 8 Oldlands Way | Bognor Regis, West Sussex P= O22 9NQ, UK |+44 1243 843222
Australia: Level 4 | 600 Bourke St | Melbourne | Victoria 3000 | = Australia | +61 7 3859 9611
Asia: No. 18 Capitol Singapore, 13 Stamford Road, #02-11 | Singap= ore 178905 | +65 6643 8000
Update Subscription Preferences | Unsubscribe
= We respect your privacy. See our privacy policy
About Wiley | Contact Customer Service

=A9 Joh= n Wiley & Sons, Inc. All rights reserved.
3D''